Results 81 to 90 of about 25,220 (171)
Intra-host Ebola viral adaption during human infection
Biosafety and Health, 2019 The onsite next generation sequencing (NGS) of Ebola virus (EBOV) genomes during the 2013–2016 Ebola epidemic in Western Africa provides an opportunity to trace the origin, transmission, and evolution of this virus.
William J. Liu +32 more
doaj +1 more source
Estimating the Reproduction Number of Ebola Virus (EBOV) During the 2014 Outbreak in West Africa
PLoS Currents, 2014 Published version, PLOS Currents Outbreaks.
openaire +5 more sources
Virus-encoded miRNAs in Ebola virus disease
Scientific Reports, 2018 Ebola virus (EBOV) is a negative-strand RNA virus that replicates in the cytoplasm and causes an often-fatal hemorrhagic fever. EBOV, like other viruses, can reportedly encode its own microRNAs (miRNAs) to subvert host immune defenses.
Janice Duy +18 more
doaj +1 more source
Specific and visual detection of EBOV based on a one-pot RT-RAA-CRISPR/Cas12a assay. [PDF]
Virol SinHuang Z +11 more
europepmc +4 more sources
Modeling Ebola Virus Transmission Using Ferrets
mSphere, 2018 Ebola virus (EBOV) has been responsible for sporadic outbreaks in Central Africa since 1976 and has the potential of causing social disruption and public panic as illustrated by the 2013–2016 epidemic in West Africa.
Marc-Antoine de La Vega +7 more
doaj +1 more source
Acta Microbiologica HellenicaEbola virus (EBOV) causes Ebola virus disease (EVD), a severe hemorrhagic fever that has high case fatality rates (CFR). Although previous Ebola miRNA research has mainly focused on host miRNA expression during infection, it has been shown that the Ebola virus also encodes miRNAs.
Melvin Mensah-Bonsu +3 more
openaire +1 more source
Development of a Pentacistronic Ebola Virus Minigenome System
VirusesEbola virus (EBOV) causes severe disease outbreaks in humans with high case fatality rates. EBOV requires adaptation to cause lethal disease in mice by acquiring single mutations in both the nucleoprotein (NP) and VP24 genes. As an attempt to model mouse-
Brady N. Zell +6 more
doaj +1 more source
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
Human Vaccines & Immunotherapeutics, 2018 The devastating Ebola virus (EBOV) epidemic in West Africa in 2013–2016 accelerated the progress of several vaccines and antivirals through clinical trials, including the replication-competent vesicular stomatitis virus-based vaccine expressing the EBOV ...
Ellen Suder +4 more
doaj +1 more source
2: Laboratory Values From Positive EBOV Patients [PDF]
American Journal of Clinical Pathology, 2015 Emily L. Ryan, Charles E. Hill
openaire +1 more source
Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity
Journal of VirologyABSTRACT MIL77-3 is one component of antibody cocktail that is produced in our lab and represents an effective regimen for animals suffering from Zaire Ebolavirus (EBOV) infection. MIL77-3 is engineered to increase its affinity for the FcγRIIIa (CD16a) by deleting the fucose in the framework region ...
Yuting Zhang +17 more
openaire +2 more sources